# Post Operative Infusion Pump Pain Study

> **NCT07349810** · PHASE4 · RECRUITING · sponsor: **Rutgers, The State University of New Jersey** · enrollment: 80 (estimated)

## Conditions studied

- Post Operative Pain

## Interventions

- **DRUG:** Bupivacaine 0.5% Injectable Solution
- **DRUG:** Ropivacaine 0.2% Injectable Solution
- **DRUG:** 1.3% liposomal bupivacaine (Exparel)
- **DEVICE:** ambIT Infusion Pump

## Key facts

- **NCT ID:** NCT07349810
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07349810

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07349810, "Post Operative Infusion Pump Pain Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07349810. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*